GlassScriptPhysician profile
Sanjay G Khicha
NPI 1811054992
$15,285.62
in general payments reported to CMS, 2019-2025
19 companies · $632 in 2025
The $632 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,156 · 2020: $1,829 · 2021: $2,352 · 2022: $1,392 · 2023: $1,632 · 2024: $3,293 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,300 · Travel and Lodging: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,299.79 |
| Travel and Lodging | $1,257.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,616.46 | 2019-2020 | |
| Medtronic, INC. | $3,165.70 | 2021-2025 | Corevalve Evolut R, Micra, Onyx Frontier |
| Atricure, INC. | $2,206.90 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Abiomed | $1,499.00 | 2019-2024 | Impella |
| Edwards Lifesciences Corporation | $1,431.96 | 2019-2024 | Konect Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Depuy Synthes Sales INC. | $975.17 | 2022-2025 | Trumatch, Na, Matrixrib |
| Abbott Laboratories | $760.33 | 2019-2025 | Assurity, Aveir, Navitor |
| Ethicon US, LLC | $541.95 | 2019-2025 | Vistaseal, Ethicon |
| W. L. Gore & Associates, INC. | $333.13 | 2019-2023 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Altathera Pharmaceuticals LLC | $222.04 | 2024 | Sotalol Hydrochloride |
| Angiodynamics, INC. | $155.54 | 2020-2025 | Angiovac |
| La Jolla Pharmaceutical Company | $131.75 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $124.97 | 2021 | |
| Haemonetics Corporation | $34.39 | 2025 | Teg6s Hemostasis System |
| Getinge USA Sales, LLC | $24.31 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $19.29 | 2025 | Na |
| Titan Surgical Group, LLC | $17.66 | 2024 | |
| Boston Scientific Corporation | $12.99 | 2020 | |
| Ge Healthcare | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Khicha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.